
A recent report from the analysis firm GlobalData predicts great prospects for the future of the Danish pharmaceutical sector – the Danish market growth is powered by a number of factors.
GlobalData estimates that revenue from the Danish market will increase from 4 billion dollars in 2011 to 7.3 billion dollars in 2020, giving it an annual growth rate (CAGR) of 6.9 %.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app